Key findings from the third installment of 'Medicare Advantage Money Grab'
- Medicare Advantage health plans collect billions of dollars from controversial “house calls.” Insurers say the visits improve patient care, but critics argue they inflate costs needlessly.
- Federal regulators proposed banning the home visits earlier this year, citing “little evidence” they led to any treatment. But officials backed down in the face of fierce industry opposition.
- The home visits are part of a thriving data analysis industry that is helping Medicare Advantage plans maximize revenues as federal officials struggle to control costs.
- As Medicare Advantage enrollment grows, the industry is amassing political clout in Congress that is muting criticism the health plans overcharge the government by billions of dollars every year.